Retraction
SOX2 Enhances the Migration and Invasion of Ovarian Cancer Cells via Src Kinase
Paper Information
Record ID:
49741
Author(s):
Publication Date:
June 17, 2014
Retraction Date:
November 28, 2023
(2.0 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0295163Additional Notes:
ssee also: https://pubpeer.com/publications/31D596D4A6179AFEB2202BE3FDEF9B
Citations (54)
54
Total Citations7
Post-Retraction(13.0%)
46
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
1
Within 30 days
4
Within 1 year
0
After 2+ years
551
Days since retraction (latest)
Elevated SNHG1 promotes invasion and migration of Cd(II)-transformed cells through Sox2, Rac1, and Slug
Zhuo Zhang, Jingxia Li, Dean Willis et al. (5 authors)
Toxicology and Applied Pharmacology
Published: Jun 2025
551 days after retraction
RETRACTED: Procópio de Oliveira et al. Potential Protective Role of Melatonin in Benign Mammary Cells Reprogrammed by Extracellular Vesicles from Malignant Cells. Biomedicines 2023, 11, 2837
Caroline Procópio de Oliveira, Barbara Maria Frigieri, Heidge Fukumasu et al. (6 authors)
Biomedicines
Open Access
Published: Apr 2025
513 days after retraction
AKT1 as a therapeutic target for platinum-resistant SOX2positive ovarian cancer cells
Mengyang Xue, Kang Li, Yunfeng Zhang et al. (7 authors)
Research Square (Research Square)
Open Access
Published: Dec 2024
372 days after retraction
Dissecting SOX2 expression and function reveals an association with multiple signaling pathways during embryonic development and in cancer progression
Niharika Niharika, Lina Ureka, Ankan Roy et al. (4 authors)
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Published: Jun 2024
3 citations
3 citations
200 days after retraction
Comparative Analysis of Primary Ovarian Cancer Cells and Established Cell Lines as a New Tool for Studies on Ovarian Cancer Cell Complexity
Agnieszka Szyposzyńska, Aleksandra Bielawska‐Pohl, Maria Paprocka et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: May 2024
169 days after retraction
Assessment of Immunohistochemical Expression of SOX2 and its Prognostic Significance in Prostatic Adenocarcinoma
Dalia Ibrahim Mohamed, Amr A.M. Kamel, Mohamed K. E. Kherbetawy
Suez Canal University Medical Journal
Open Access
Published: Jan 2024
34 days after retraction
Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer
Ji Wang, James Ford, Anirban K. Mitra
Biology
Open Access
Published: Dec 2023
1 citation
1 citation
7 days after retraction
Retraction: SOX2 Enhances the Migration and Invasion of Ovarian Cancer Cells via Src Kinase
Unknown Authors
PLoS ONE
Open Access
Published: Nov 2023
Same day as retraction
E3 ubiquitin ligase RNF180 impairs IPO4/SOX2 complex stability and inhibits SOX2-mediated malignancy in ovarian cancer
Haiyan Zhao, Fangfang Bi, Mengyuan Li et al. (5 authors)
Cellular Signalling
Published: Nov 2023
3 citations
3 citations
26 days before retraction
Mesenchymal Stem Cell Microvesicles from Adipose Tissue: Unraveling Their Impact on Primary Ovarian Cancer Cells and Their Therapeutic Opportunities
Agnieszka Szyposzyńska, Aleksandra Bielawska‐Pohl, Marek Murawski et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Nov 2023
7 citations
7 citations
27 days before retraction
Prognostic Implications of CD24, SOX2, and Nanog Expression in Invasive Urothelial Carcinoma
Abeer M. Abdelbary, Hanaa Atwa, Ola M. Elfarargy et al. (5 authors)
Applied immunohistochemistry & molecular morphology
Published: Jun 2023
5 citations
5 citations
174 days before retraction
SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway
Ying Wang, Xia Luo, Nayiyuan Wu et al. (5 authors)
Medical Oncology
Open Access
Published: Jan 2023
10 citations
10 citations
322 days before retraction
Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
Kharimat Lora Alatise, Samantha Gardner, Angela Alexander-Bryant
Cancers
Open Access
Published: Dec 2022
59 citations
59 citations
345 days before retraction
SOX2 function in cancers: Association with growth, invasion, stemness and therapy response
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Maliheh Entezari et al. (14 authors)
Biomedicine & Pharmacotherapy
Published: Oct 2022
44 citations
44 citations
404 days before retraction
SOX2 Promotes Invasion in Human Bladder Cancers through MMP2 Upregulation and FOXO1 Downregulation
Qipeng Xie, Xiaohui Hua, Chao Huang et al. (10 authors)
International Journal of Molecular Sciences
Open Access
Published: Oct 2022
9 citations
9 citations
405 days before retraction
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer
Zainab Shonibare, Mehri Monavarian, Kathleen O’Connell et al. (17 authors)
Cell Reports
Open Access
Published: Jul 2022
33 citations
33 citations
515 days before retraction
Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer
Mariana Nunes, Francisca Pacheco, Ricardo Coelho et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Jan 2022
5 citations
5 citations
679 days before retraction
Suppression of EGFR/PKC-δ/NF-κB Signaling Associated With Imipramine-Inhibited Progression of Non-Small Cell Lung Cancer
Po‐Fu Yueh, Yuan‐Hao Lee, I‐Tsang Chiang et al. (7 authors)
Frontiers in Oncology
Open Access
Published: Oct 2021
22 citations
22 citations
763 days before retraction
KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer
Jing Chen, Cuicui Zhao, Fei-Ran Chen et al. (6 authors)
Journal of Oncology
Open Access
Published: Sep 2021
11 citations
11 citations
810 days before retraction
Multi-Omics Analysis of SOX4, SOX11, and SOX12 Expression and the Associated Pathways in Human Cancers
Jaekwon Seok, Minchan Gil, Ahmed Abdal Dayem et al. (5 authors)
Journal of Personalized Medicine
Open Access
Published: Aug 2021
14 citations
14 citations
827 days before retraction
SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression
Zahra Hosseini‐khah, Mohammad Reza Babaei, Mohsen Tehrani et al. (9 authors)
Current Oncology
Open Access
Published: Aug 2021
12 citations
12 citations
841 days before retraction
The role of Yamanaka cocktail transcription factors (OCT4, SOX2, KLF4, c-Myc) in the differentiation of somatic cells, their malignant transformation, and tumor progression
Л. Е. Гуревич, E. V. Bondarenko, O.A. Vasyukova et al. (4 authors)
CLINICAL AND EXPERIMENTAL MORPHOLOGY
Open Access
Published: Jan 2021
2 citations
2 citations
1061 days before retraction
SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA
Ruiyan Wu, Caiqin Wang, Zhiming Li et al. (19 authors)
Journal for ImmunoTherapy of Cancer
Open Access
Published: Nov 2020
44 citations
44 citations
1122 days before retraction
Characterization of SOX2, OCT4 and NANOG in ovarian cancer tumor-initiating cells
Mikella Robinson, Samuel F. Gilbert, Jennifer A. Waters et al. (12 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Sep 2020
3 citations
3 citations
1174 days before retraction
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
Maria Bååth, Sofia Westbom-Fremer, Laura Martín de la Fuente et al. (9 authors)
Molecular & Cellular Oncology
Open Access
Published: Sep 2020
8 citations
8 citations
1179 days before retraction
Cancer and SOX proteins: New insight into their role in ovarian cancer progression/inhibition
Milad Ashrafizadeh, Shahram Taeb, Kiavash Hushmandi et al. (11 authors)
Pharmacological Research
Published: Aug 2020
36 citations
36 citations
1198 days before retraction
Functional characterization of SOX2 as an anticancer target
Shizhen Zhang, Xiufang Xiong, Yi Sun
Signal Transduction and Targeted Therapy
Open Access
Published: Jul 2020
160 citations
160 citations
1217 days before retraction
The miR-567/RPL15/TGF-β/Smad axis inhibits the stem-like properties and chemo-resistance of gastric cancer cells
Yuan Ma, Xue Hua, Weifeng Wang et al. (5 authors)
Translational Cancer Research
Open Access
Published: May 2020
5 citations
5 citations
1306 days before retraction
Block of proliferation 1 promotes cell migration and invasion in human colorectal cancer cells via the JNK pathway
Xiaoxi Chen, Yu Zhao
Journal of Clinical Laboratory Analysis
Open Access
Published: Mar 2020
10 citations
10 citations
1355 days before retraction
miR-485-5p improves the progression of ovarian cancer by targeting SRC in vitro and in vivo
Yan Yang, Jingke Liu, Xiaohua Qian et al. (6 authors)
Neoplasma
Open Access
Published: Jan 2020
15 citations
15 citations
1427 days before retraction
Migration dynamics of ovarian epithelial cells on micro-fabricated image-based models of normal and malignant stroma
Samuel Alkmin, Rebecca Brodziski, Haleigh Simon et al. (7 authors)
Acta Biomaterialia
Open Access
Published: Sep 2019
14 citations
14 citations
1522 days before retraction
SOX2 in development and cancer biology
Daniel Novak, Laura Hüser, Jonathan J. Elton et al. (6 authors)
Seminars in Cancer Biology
Open Access
Published: Aug 2019
304 citations
304 citations
1570 days before retraction
The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 protein
Xiaohui Hua, Maowen Huang, Xu Deng et al. (14 authors)
Cell Death and Differentiation
Open Access
Published: Jun 2019
24 citations
24 citations
1616 days before retraction
Metastatic potential and prognostic significance of SOX2: A meta-analysis
Arslaan Javaeed, Sanniya Khan Ghauri
World Journal of Clinical Oncology
Open Access
Published: Jun 2019
8 citations
8 citations
1618 days before retraction
The role of SOX family members in solid tumours and metastasis
Daniela Grimm, Johann Bauer, Petra M. Wise et al. (8 authors)
Seminars in Cancer Biology
Open Access
Published: Mar 2019
351 citations
351 citations
1711 days before retraction
SOX2 knockdown inhibits the migration and invasion of basal cell carcinoma cells by targeting the SRPK1‑mediated PI3K/AKT signaling pathway
Zhuo‐Ran Li, Yong Jiang, Jianzhong Hu et al. (5 authors)
Oncology Letters
Open Access
Published: Dec 2018
15 citations
15 citations
1817 days before retraction
High expression of LASS2 is associated with unfavorable prognosis in patients with ovarian cancer
Ning Sheng, Yanyan Wang, Ying Xie et al. (12 authors)
Journal of Cellular Physiology
Published: Dec 2018
10 citations
10 citations
1817 days before retraction
Targeting SOX2 in anticancer therapy
Laura Hüser, Daniel Novak, Viktor Umansky et al. (5 authors)
Expert Opinion on Therapeutic Targets
Published: Oct 2018
77 citations
77 citations
1859 days before retraction
SOX2‐mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma
Laura Hüser, Sachindra Sachindra, Karol Granados et al. (9 authors)
International Journal of Cancer
Open Access
Published: Jun 2018
62 citations
62 citations
1992 days before retraction
Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells
Ritsuko Harigai, Shigeki Sakai, Hiroyuki Nobusue et al. (14 authors)
Scientific Reports
Open Access
Published: Apr 2018
17 citations
17 citations
2057 days before retraction
Cancer Stem Cell–Suppressing Activity of Chrysotoxine, a Bibenzyl from<i>Dendrobium pulchellum</i>
Narumol Bhummaphan, Varisa Pongrakhananon, Boonchoo Sritularak et al. (4 authors)
Journal of Pharmacology and Experimental Therapeutics
Open Access
Published: Dec 2017
26 citations
26 citations
2182 days before retraction
The dark side of SOX2: cancer - a comprehensive overview
Erin L. Wuebben, Angie Rizzino
Oncotarget
Open Access
Published: Mar 2017
203 citations
203 citations
2439 days before retraction
Sox2-dependent inhibition of p21 is associated with poor prognosis of endometrial cancer
Kaoru Yamawaki, Tatsuya Ishiguro, Yutaro Mori et al. (13 authors)
Cancer Science
Open Access
Published: Feb 2017
31 citations
31 citations
2481 days before retraction
CMV70-3P miRNA contributes to the CMV mediated glioma stemness and represents a target for glioma experimental therapy
Ilya V. Ulasov, Natalya Kaverina, Dhimankrishna Ghosh et al. (8 authors)
Oncotarget
Open Access
Published: Aug 2016
30 citations
30 citations
2666 days before retraction
SOX-mediated molecular crosstalk during the progression of tumorigenesis
Yaru Xu, Wan‐Xi Yang
Seminars in Cell and Developmental Biology
Published: Jul 2016
45 citations
45 citations
2678 days before retraction
SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells
Erin L. Wuebben, Phillip J. Wilder, Jesse L. Cox et al. (7 authors)
Oncotarget
Open Access
Published: Apr 2016
33 citations
33 citations
2772 days before retraction
Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?
Issam Chebouti, Christina Blassl, Pauline Wimberger et al. (7 authors)
Oncotarget
Open Access
Published: Apr 2016
11 citations
11 citations
2797 days before retraction
SOX2 Expression in Cervical Intraepithelial Neoplasia Grade 3 (CIN3) and Superficially Invasive (Stage IA1) Squamous Carcinoma of the Cervix
Colin J.R. Stewart, Maxine L. Crook
International Journal of Gynecological Pathology
Published: Feb 2016
12 citations
12 citations
2841 days before retraction
Roles of human VRK1 Ser-Thr kinase in the regulation of cell proliferation
David S. Moura
Unknown Journal
Open Access
Published: Jan 2016
2888 days before retraction
Effects of SOX2 on Proliferation, Migration and Adhesion of Human Dental Pulp Stem Cells
Pengfei Liu, Jinglei Cai, Delu Dong et al. (7 authors)
PLoS ONE
Open Access
Published: Oct 2015
44 citations
44 citations
2958 days before retraction
Quick Stats
Total Citations:
54
Years Since Retraction:
2.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025